Research lineage

Intellectual lineage — not immutable doctrine.

Earlier research is treated as intellectual lineage, not immutable doctrine. Constructs may be survived, transformed, revalidation-required, superseded, or retired as evidence develops.

Construct status vocabulary

  • SURVIVED Retained with continuing relevance under current evidence.
  • TRANSFORMED Concepts carried forward in altered form.
  • REVALIDATION_REQUIRED Must be re-tested before further public or product use.
  • SUPERSEDED Replaced by a later construct.
  • RETIRED No longer active in the research programme.
  1. 2025

    MMCQ / early consciousness-dynamics research

    TRANSFORMED
    • recursive coherence
    • observer dynamics
    • symbolic organization
    • state transitions
    • collapse / reorganization

    Ancestry. Not a public product claim. Unpublished mathematics and IP are not disclosed here.

  2. 2026

    Consequential Epistemic Control

    SURVIVED
    • evidence
    • uncertainty
    • authority
    • derivation
    • consequence
    • repair

    Active / validating programme linking research to the Guardian technical preview.

  3. Revalidation required before further public or product use

    NEXT

    Epistemic Dynamics / CRX

    REVALIDATION_REQUIRED
    • epistemic state over time
    • causal study of consciousness-relevant computational mechanisms

    Experimental path. Not present validation.

  4. Revalidation required before further public or product use

    NEXT

    Counterfactual Discovery

    REVALIDATION_REQUIRED
    • cross-world experimentation
    • invariance
    • transfer

    Frontier research. Simulation is not reality validation.

MMCQ ancestry CEC Epistemic Dynamics / CRX Counterfactual Discovery

Disclaimer. Earlier research is treated as intellectual lineage, not immutable doctrine. LUXION may preserve, transform, revalidate, supersede, or retire constructs as evidence develops. Confidential and unpublished IP are not exposed on this page.

Back to programmes

Discuss architecture fit, sector context, evidence maturity, and controlled deployment pathways.

Or email [email protected]